BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177 | -46.7% | 25 | -50.0% | 0.00% | – |
| Q2 2023 | $332 | +104.9% | 50 | +92.3% | 0.00% | – |
| Q1 2023 | $162 | +362.9% | 26 | -99.5% | 0.00% | -100.0% |
| Q4 2022 | $35 | -99.9% | 5,543 | -3.6% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | 0.0% | 5,751 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $36,000 | -2.7% | 5,751 | -1.3% | 0.00% | – |
| Q1 2022 | $37,000 | +3600.0% | 5,829 | +7373.1% | 0.00% | – |
| Q4 2021 | $1,000 | -85.7% | 78 | -85.5% | 0.00% | – |
| Q3 2021 | $7,000 | -95.0% | 538 | -93.9% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | +122.2% | 8,822 | +44.6% | 0.00% | +200.0% |
| Q1 2021 | $63,000 | +14.5% | 6,099 | -16.4% | 0.00% | -50.0% |
| Q4 2020 | $55,000 | +685.7% | 7,295 | +231.6% | 0.00% | – |
| Q3 2020 | $7,000 | – | 2,200 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -70.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |